Chronic Lower Back Pain Global Market Opportunities And Strategies To 2034
상품코드:1695938
리서치사:The Business Research Company
발행일:2025년 03월
페이지 정보:영문 316 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
전 세계 만성 요통 시장 규모는 2019년 67억 9,252만 달러로 2024년까지 2.00% 이상의 CAGR로 성장할 것으로 예상됩니다.
유리한 정부 정책
유리한 정부 이니셔티브는 지난 기간 동안 만성 요통 시장의 성장을 지원했습니다. 많은 국가의 정부는 의료 인프라 개선, 보험 적용 범위 확대, 치료비 보조금 지원 등의 정책을 시행하여 만성 요통 환자들이 쉽게 치료받고 경제적으로 여유를 가질 수 있도록 하고 있습니다. 이러한 노력에는 만성 통증에 특화된 통증 관리 프로그램이나 클리닉의 개발이 포함되는 경우가 많습니다. 예를 들어, 2021년 8월 독일 정부는 FPZ(Research and Prevention Center) 컨셉을 개발하여 수십만 명의 환자들에게 요통 완화를 제공하는 매우 효과적인 치료 프로그램을 개발했습니다. 이 접근법은 종합적인 평가와 척추를 안정화시키는 근육을 강화하도록 설계된 개별 훈련 요법을 결합합니다. 치료는 생역학적 문제를 파악하는 초기 평가, 근력과 유연성에 초점을 맞춘 맞춤형 훈련 프로그램, 재발 방지를 위한 지속적인 유지 관리의 3단계로 구성됩니다. 연구에 따르면 환자의 약 93.5%가 통증을 완화할 수 있으며, 많은 환자들이 완전한 회복과 근력 및 이동성이 크게 향상되었다고 보고하고 있습니다. 따라서, 유리한 정부 이니셔티브는 만성 요통 시장의 성장을 촉진했습니다.
세계의 만성 요통 시장에 대해 조사 분석했으며, 시장의 특징, 주요 시장 동향, 시장 규모와 성장 전망, 경쟁 구도 등의 정보를 전해드립니다.
목차
제1장 주요 요약
만성 요통 - 시장 매력과 거시경제 상황
제2장 목차
제3장 표목차
제4장 그림목차
제5장 보고서 구성
제6장 시장 특징
일반적인 시장 정의
요약
만성 요통 시장 정의와 세분화
시장 세분화 : 통증 유형별
추간판성 통증
요부 척추관 협착증
천장관절통
추간관절통
신경근통
근육통
기타 통증 유형
시장 세분화 : 진단별
병력
신체검사
이미징 가이드라인
통증 평가
시장 세분화 : 최종사용자별
병원
정형외과 클리닉
외래 수술 센터
기타 최종사용자
제7장 주요 시장 동향
비수술적 요통 및 다리 통증 치료에 승인된 혁신적인 척수 자극법
AI를 활용한 척수 자극으로 통증 치료를 재정의
척수 자극 기술로 만성 요통 치료의 혁명
AI와 의학적 지식을 활용한 맞춤형 요통 솔루션
다양한 원인으로 인한 만성 통증을 관리할 수 있는 첨단 치료 시설
최첨단 TGF-B 조절 요법, 임상 시험에서 진전을 이루다
제8장 만성 요통 시장 - 거시경제 시나리오
만성 요통 시장에 대한 COVID-19의 영향
만성 요통 시장에 대한 우크라이나 전쟁의 영향
만성 요통 시장에 대한 고인플레이션의 영향
제9장 세계의 시장 규모와 성장
시장 규모
시장 성장 실적(2019-2024년)
시장 성장 촉진요인(2019-2024년)
시장 성장 억제요인(2019-2024년)
시장 성장 예측(2024-2029년·2034년)
시장 성장 촉진요인(2024-2029년)
시장 성장 억제요인(2024-2029년)
제10장 세계의 만성 요통 시장 세분화
세계의 만성 요통 시장 : 통증 유형별, 실적과 예측(2019-2024년·2029년·2034년)
세계의 만성 요통 시장 : 진단별, 실적과 예측(2019-2024년·2029년·2034년)
세계의 만성 요통 시장 : 최종사용자별, 실적과 예측(2019-2024년·2029년·2034년)
제11장 만성 요통 시장, 지역과 국가 분석
세계의 만성 요통 시장 : 지역별, 실적과 예측(2019-2024년·2029년·2034년)
세계의 만성 요통 시장 : 국가별, 실적과 예측(2019-2024년·2029년·2034년)
제12장 아시아태평양 시장
제13장 서유럽 시장
제14장 동유럽 시장
제15장 북미 시장
제16장 남미 시장
제17장 중동 시장
제18장 아프리카 시장
제19장 경쟁 구도와 기업 개요
기업 개요
Johnson & Johnson
Pfizer Inc
Novartis AG
Medtronic Inc
Eli Lilly and Company
제20장 기타 주요 기업과 혁신적 기업
Hisamitsu Pharmaceutical Co. Inc
Boehringer Ingelheim GmbH
AstraZeneca plc
Endo International plc
AbbVie Inc
Grunenthal GmbH
Amgen Inc
Teva Pharmaceutical Industries Ltd
Collegium Pharmaceutical Inc
Merck & Co. Inc
BioWave Corporation
Boston Scientific Corporation
Abbott Laboratories
Vertebral Technologies Inc
Neuraxpharm Group
제21장 경쟁 벤치마킹
제22장 경쟁 대시보드
제23장 주요 인수합병
Boston Scientific Acquired Relievant Medsystems To Expand Chronic Pain Management Portfolio
Stryker Corporation Acquired Vertos Medical To Enhance Minimally Invasive Pain Management Portfolio
Silony Medical International AG Acquired Centinel Fusion Portfolio To Improve Treatment Options
제24장 기회와 전략
세계의 만성 요통 시장 - 가장 새로운 기회를 제공하는 국가(2029년)
세계의 만성 요통 시장 - 가장 새로운 기회를 제공하는 부문(2029년)
세계의 만성 요통 시장 - 성장 전략(2029년)
시장 동향에 기반한 전략
경쟁 전략
제25장 만성 요통 시장 : 결론과 제안
결론
제안
제품
유통
가격
프로모션
사람들
제26장 부록
ksm
영문 목차
영문목차
The chronic lower back pain market consists of sales, by entities (organizations, sole traders and partnerships) that arise from a variety of underlying causes, including structural, neurological and muscular issues and its management requires tailored approaches depending on the pain type and severity. Chronic low back pain is the major cause of disability and psychological issues such as stress, depression and/or anxiety.
Patients experiencing chronic lower back pain may seek medical attention from healthcare providers such as general practitioners, orthopedic specialists, neurologists and physiotherapists. The condition is commonly managed through diagnostic and treatment pathways involving clinical evaluations, imaging studies and interventional or non-interventional therapies. Treatment options range from pharmacological approaches, such as analgesics and anti-inflammatory drugs, to physical therapy, surgical interventions and alternative methods such as acupuncture or chiropractic care. The management of CLBP is often multidisciplinary, involving collaboration between specialists and support teams to ensure optimal outcomes.
The global chronic lower back pain market was valued at $6,792.52 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 2.00%.
Favorable Government Initiatives
The favorable government initiatives supported the growth of the chronic lower back pain market in the historic period. Governments in many countries have implemented policies aimed at improving healthcare infrastructure, increasing insurance coverage and subsidizing treatments, making it easier for individuals with chronic lower back pain to seek and afford care. These initiatives often include the development of specialized pain management programs and clinics, which provide focused attention on chronic pain conditions. For example, in August 2021, government of Germany developed the FPZ (Research and Prevention Center) Concept is a highly effective treatment program, that has provided back pain relief to hundreds of thousands of patients. This approach combines comprehensive assessments with individualized training regimens designed to strengthen the spine's stabilizing musculature. The treatment consists of three phases: an initial assessment to identify biomechanical issues, a customized training program focusing on strength and flexibility and ongoing maintenance to prevent recurrence. Research shows that approximately 93.5% of patients experience pain relief, with many reporting complete recovery, alongside significant improvements in strength and mobility. Therefore, favorable government initiatives drove the growth of the chronic lower back pain market.
Companies operating in the chronic lower back pain market are focusing on artificial intelligence (AI)- infused spinal cord stimulation redefines pain therapy. This technology improves the accuracy and efficacy of treatment but also reduces the need for manual adjustments by healthcare providers, leading to better patient outcomes. For instance, in September 2024, Nevro, a US-based medical device company, launched HFX AdaptivAI (High-Frequency Stimulation Adaptive Artificial Intelligence), an innovative spinal cord stimulation technology that incorporates artificial intelligence to enhance pain management for chronic pain sufferers. This technology is positioned as a unique solution within the spinal cord stimulation market, promising improved patient outcomes through adaptive therapy. HFX AdaptivAI delivers personalized pain relief, utilizing AI and leveraging millions of data points and ten years of innovation and patient care.
The global chronic lower back pain market is concentrated, with large players operating in the market. The top ten competitors in the market made up to 42.25% of the total market in 2023.
Chronic Lower Back Pain Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global chronic lower back pain market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for chronic lower back pain? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The chronic lower back pain market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider chronic lower back pain market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type of pain, by diagnosis and by end-user.
Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario - The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the chronic lower back pain market.
Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type of pain, by diagnosis and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for chronic lower back pain providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Type Of Pain: Diskogenic Pain; Lumbar Spinal Stenosis; Sacroiliac Pain; Facet-Joint Pain; Radicular Pain; Muscular Pain; Other Types Of Pain
2) By Diagnosis: Clinical History; Physical Examination; Imaging Guidelines; Assessment Of Pain
3) By End-User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End-Users
Companies Mentioned: Johnson & Johnson Services Inc.; Pfizer Inc.; Novartis AG; Medtronic plc; Eli Lilly and Company; Hisamitsu Pharmaceutical Co. Inc.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; chronic lower back pain indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1 Executive Summary
1.1 Chronic Lower Back Pain - Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Chronic Lower Back Pain Market Definition And Segmentations
6.4 Market Segmentation By Type Of Pain
6.4.1 Diskogenic Pain
6.4.2 Lumbar Spinal Stenosis
6.4.3 Sacroiliac Pain
6.4.4 Facet-Joint Pain
6.4.5 Radicular Pain
6.4.6 Muscular Pain
6.4.7 Other Types Of Pain
6.5 Market Segmentation By Diagnosis
6.5.1 Clinical History
6.5.2 Physical Examination
6.5.3 Imaging Guidelines
6.5.4 Assessment Of Pain
6.6 Market Segmentation By End-User
6.6.1 Hospitals
6.6.2 Orthopedic Clinics
6.6.3 Ambulatory Surgery Centers
6.6.4 Other End-Users
7 Major Market Trends
7.1 Innovative Spinal Cord Stimulation Approved For Non-Surgical Back And Leg Pain
